Showing 141 - 160 results of 240 for search '"hepatitis B virus"', query time: 0.06s Refine Results
  1. 141

    Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention by Shuai-Wen Huang, Hong Long, Jia-Quan Huang

    Published 2024-12-01
    “…However, even after HBsAg loss, hepatitis B virus can persist, with a risk of recurrence, reactivation, cirrhosis, and hepatocellular carcinoma. …”
    Get full text
    Article
  2. 142

    Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients by Emily L. Heil, Mary L. Townsend, Kenneth Shipp, Amy Clarke, Melissa D. Johnson

    Published 2010-01-01
    “…Patients were excluded if they had active or chronic hepatitis B virus (HBV). The primary objective was to determine the overall incidence of severe hepatotoxicity. …”
    Get full text
    Article
  3. 143

    HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication by André Boonstra, Gulce Sari

    Published 2025-01-01
    “…Hepatitis B virus (HBV) is a major global health issue, with an estimated 254 million people living with chronic HBV infection worldwide as of 2022. …”
    Get full text
    Article
  4. 144

    Clinical Relevance of HLA Gene Variants in HBV Infection by Li Wang, Zhi-Qiang Zou, Kai Wang

    Published 2016-01-01
    “…Host gene variants may influence the natural history of hepatitis B virus (HBV) infection. The human leukocyte antigen (HLA) system, the major histocompatibility complex (MHC) in humans, is one of the most important host factors that are correlated with the clinical course of HBV infection. …”
    Get full text
    Article
  5. 145

    Viral hepatitis B epidemiology in Sakha republic (Yakutia) by S. I. Semenov, R. G. Savvin, S. G. Nikitina, S. S. Maksimova, V. G. Krivoshapkin, S. S. Sleptsova

    Published 2015-09-01
    “…According to EIA results the prevalence of hepatitis B virus infection markers in population corresponds to criteria of intermediate intensity and for hepatitis D virus — to high intensity.Conclusions. …”
    Get full text
    Article
  6. 146

    Feedback control of an HBV model based on ensemble kalman filter and differential evolution by Junyoung Jang, Kihoon Jang, Hee-Dae Kwon, Jeehyun Lee

    Published 2018-05-01
    “…In this paper, we derive efficient drug treatment strategies for hepatitis B virus (HBV) infection by formulating a feedback control problem. …”
    Get full text
    Article
  7. 147

    Entecavir-Associated Thrombocytopenia: A Case Report and Review of the Pathophysiology, Diagnosis, and Treatment of a Rare but Reversible Cause of Thrombocytopenia by Binoy Yohannan, Dai Chu N. Luu, Mark Feldman

    Published 2019-01-01
    “…She had undergone screening for hepatitis B virus (HBV) prior to starting rituximab and was found to have hepatitis B core serum antibody (IgG anti-HBc). …”
    Get full text
    Article
  8. 148

    From the right ventricle to the descending aorta: a Case Report of complex thrombotic events in a patient with nephrotic syndrome by Jiaojiao Chen, Longyin Zhu, Fen Zhou, Yuting Li, Tao Gu, Jing Xia

    Published 2025-01-01
    “…The etiological diagnosis was hepatitis B virus-associated glomerulonephritis, and the pathological diagnosis was mesangial proliferative glomerulonephritis. …”
    Get full text
    Article
  9. 149

    High Steroid Sensitivity among Children with Nephrotic Syndrome in Southwestern Nigeria by Taiwo Augustina Ladapo, Christopher Imokhuede Esezobor, Foluso Ebun Lesi

    Published 2014-01-01
    “…No cases of quartan malaria nephropathy or hepatitis B virus nephropathy were diagnosed. Overall mortality was 6.5%. …”
    Get full text
    Article
  10. 150

    Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus by Youssif Bahaa G. M., Mohamed Yaseen A. M., Salim Mohammed T. A., Inagaki Fuyuhiko, Mukai Chisato, Abdu-Allah Hajjaj H. M.

    Published 2016-06-01
    “…New derivatives of 2-thiobenzimidazole incorporating triazole moiety were synthesized, characterized and tested in vitro for antiviral activity against hepatitis C virus (HCV) and hepatitis B virus (HBV). Their cytotoxicity was determined by the reduction in the number of viable cell. …”
    Get full text
    Article
  11. 151

    Associations between Extracellular Matrix Protein 1 Gene Polymorphism and Progression of Liver Disease by Xiuting He, Ting Liu, Rui Zhang, Xu Li

    Published 2022-01-01
    “…A total 656 patients with hepatitis B virus (HBV) infection and 298 healthy individuals of the Chinese Han population were recruited for a retrospective case-control study. …”
    Get full text
    Article
  12. 152

    Pharmacophore modeling and QSAR analysis of anti-HBV flavonols. by Basireh Baei, Parnia Askari, Fatemeh Sana Askari, Seyed Jalal Kiani, Alireza Mohebbi

    Published 2025-01-01
    “…Due to its global burden, Targeting Hepatitis B virus (HBV) infection in humans is crucial. …”
    Get full text
    Article
  13. 153
  14. 154

    Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors by Bandar Al-Knawy, Awad A El-Mekki, Jamal Hamdi, Raja Thiga, Anwar Sheikha

    Published 1995-01-01
    “…The prevalence of antibodies to hepatitis C virus (anti-HCV) was retrospectively determined using a second generation enzyme immunoassay in 3868 blood donors from the southern part of Saudi Arabia in an area with high prevalence of hepatitis B virus (HBV) infection. Of 3354 Saudis, 48 (1.43%) were seropositive for anti-HCV. …”
    Get full text
    Article
  15. 155

    A Canadian Isolate of Hepatitis D (delta) Virus by Véronique Poisson, Daniel B Ménard, Éric Frost, Jean-Pierre Perreault

    Published 2000-01-01
    “…HepatitisD(delta) virus (HDV) is an infectious agent that propagates in hepatocytes only in the presence of hepatitis B virus, causing fulminant or chronic hepatitis with liver cirrhosis. …”
    Get full text
    Article
  16. 156

    Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia by Federica Toscanini, Pasqualina De Leo, Giuseppe Calcagno, Federica Malfatti, Alessandro Grasso, Marco Anselmo

    Published 2011-01-01
    “…Hepatitis B virus (HBV) reactivation is an increasingly recognized cause of morbidity and mortality in patients undergoing chemotherapy. …”
    Get full text
    Article
  17. 157

    Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt by Ramadan A. Mahmoud, Abdel-Azeem M. El-Mazary, Ashraf Khodeary

    Published 2016-01-01
    “…The aim of this study was to estimate the prevalence of hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and cytomegalovirus (CMV) in thalassemic children attending the Pediatrics Departments of both Sohag and Minia Universities of Upper Egypt, during the period from May 2014 to May 2015. …”
    Get full text
    Article
  18. 158

    Global dynamics of a vaccination model for infectious diseases with asymptomatic carriers by Martin Luther Mann Manyombe, Joseph Mbang, Jean Lubuma, Berge Tsanou

    Published 2016-04-01
    “…Finally, a case study of hepatitis B virus disease (HBV) is considered, with the numerical simulations presented to support the analytical results. …”
    Get full text
    Article
  19. 159

    Effect of Intervention of Vaccination and Treatment on the Transmission Dynamics of HBV Disease: A Mathematical Model Analysis by Firaol Asfaw Wodajo, Temesgen Tibebu Mekonnen

    Published 2022-01-01
    “…We proposed and analyzed a compartmental nonlinear deterministic mathematical model SEACTR for transmission dynamics and control of hepatitis B virus disease. In this model, we used force infection which takes the contact rate of susceptible population and transmission probability into account. …”
    Get full text
    Article
  20. 160

    Risk factors of development of hepatocellular carcinoma by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya, I. A. Sokolina, Ye. N. German, M. V. Bundina

    Published 2009-02-01
    “…Prophylaxis of HCC should include prevention of hepatites B and C viruses infection, elimination of hepatotoxic substances, hepatitis B virus vaccination, antiviral therapy for patients with hepatites B and С. …”
    Get full text
    Article